Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYFrontiers in cellular and infection microbiology

Evaluation of the Biosynex AMPLIQUICK® Fecal Parasitology assays in a Belgian travel clinic.

  1. 1Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat, Antwerp, Belgium.
  2. 2Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland.
  3. 3Clinical Microbiology Laboratory, Geneva University Hospitals, Geneva, Switzerland.

Abstract

Introduction

Molecular diagnostics have improved infectious disease detection, yet their role in parasitology remains nuanced.Methods

We compared the performance of the AMPLIQUICK®Fecal Parasitology assay with the conventional methods encompassing microscopy, antigen testing and in-house PCR testing, in a reference laboratory for parasitology in a travel clinic. The detection of protozoa, helminths, and microsporidia was evaluated on 107 stool samples from 99 patients with suspected gastrointestinal parasitic infections, of which 40 specimens were tested retrospectively and 67 were collected prospectively.Results

AMPLIQUICK® demonstrated high accuracy for protozoa and microsporidia (94.6%, 35/37) detecting all Entamoeba histolytica, Entamoeba dispar, most Giardia duodenalis and Cryptosporidium spp., and all Enterocytozoon bieneusi and Encephalitozoon spp. The assay detected more Dientamoeba fragilis (24 vs. 12) and Blastocystis sp. (61 vs. 44) than the conventional method but the correctness of these results could not be established. AMPLIQUICK® reliably detected most clinically relevant helminths, including Ascaris lumbricoides, Strongyloides spp., Hymenolepis nana, Taenia spp., and Enterobius vermicularis. Hookworms, Trichuris trichiura, Schistosoma mansoni, Heterophyidae/Opisthorchidae and Trichostrongylus spp. were occasionally missed.Discussion

AMPLIQUICK® demonstrated good performance compared to the conventional methods and has the potential to improve parasitology diagnostics, particularly in laboratories with limited expertise. Clinicians should interpret findings in the patient's clinical context.

Related

  1. TCA precipitation and ethanol/HCl single-step purification evaluation: One-dimensional gel electrophoresis, bradford assays, spectrofluorometry and Raman spectroscopy data on HSA, Rnase, lysozyme - Mascots and Skyline data
    Balkis Eddhif, Nadia Guignard, Yann Batonneau +4
    Data in BriefPeer-reviewedCC BYFull text10 citedGeneral biochemistrySystems & synthetic biologyHAL
  2. Evaluation of the Hologic Aptima® Vaginitis and Seegene Allplex™ assays for microbiological diagnosis of bacterial vaginosis and Candida vaginitis in women in France, relative to Nugent score and culture.
    Cécile Martaresche, Florian Scherrer
    Journal of medical microbiologyPeer-reviewedCC BYFull textMicrobiologyEurope PMC
  3. Clinical Spectrum, Treatments and Outcomes of VEXAS Syndrome: A Multicenter Belgian Cohort
    L. Funaro, L. Naesens, A. Betrains +8
    medRxivPreprintCC BYFull textImmunologymedRxiv
  4. Eddy covariance diverges from inventory and model-based estimates of soil organic carbon stock change across five crop rotations in Belgian cropland
    Quentin Beauclaire, Bernard Longdoz, Laura Delhez +7
    BiogeosciencesPeer-reviewedCC BY 4.0Full textGeneral biologyClimate scienceHALCrossref
  5. Multimodal Sensitivity Enhancement of Binding-based Diagnostic Assays Using Functional Hydrogels
    P. Rajurkar, S. D. Wise, A. Sarkar
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv
BibTeX
@article{coppens2026evaluation,
  title = {{Evaluation of the Biosynex AMPLIQUICK® Fecal Parasitology assays in a Belgian travel clinic.}},
  author = {Jasmine Coppens and Jean-Marc Schwob and Karin Van Looveren and Jolien Baeyens and Marjan Van Esbroeck},
  journal = {Frontiers in cellular and infection microbiology},
  year = {2026},
  month = oct,
  doi = {10.3389/fcimb.2026.1816447},
  url = {https://europepmc.org/article/MED/42908692},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Evaluation of the Biosynex AMPLIQUICK® Fecal Parasitology assays in a Belgian travel clinic.
AU  - Jasmine Coppens
AU  - Jean-Marc Schwob
AU  - Karin Van Looveren
AU  - Jolien Baeyens
AU  - Marjan Van Esbroeck
PY  - 2026
DA  - 2026/10/07
JO  - Frontiers in cellular and infection microbiology
DO  - 10.3389/fcimb.2026.1816447
UR  - https://europepmc.org/article/MED/42908692
AB  - Introduction  Molecular diagnostics have improved infectious disease detection, yet their role in parasitology remains nuanced.Methods  We compared the performance of the AMPLIQUICK®Fecal Parasitology assay with the conventional methods encompassing microscopy, antigen testing and in-house PCR testing, in a reference laboratory for parasitology in a travel clinic. The detection of protozoa, helminths, and microsporidia was evaluated on 107 stool samples from 99 patients with suspected gastrointestinal parasitic infections, of which 40 specimens were tested retrospectively and 67 were collected prospectively.Results  AMPLIQUICK® demonstrated high accuracy for protozoa and microsporidia (94.6%, 35/37) detecting all Entamoeba histolytica, Entamoeba dispar, most Giardia duodenalis and Cryptosporidium spp., and all Enterocytozoon bieneusi and Encephalitozoon spp. The assay detected more Dientamoeba fragilis (24 vs. 12) and Blastocystis sp. (61 vs. 44) than the conventional method but the correctness of these results could not be established. AMPLIQUICK® reliably detected most clinically relevant helminths, including Ascaris lumbricoides, Strongyloides spp., Hymenolepis nana, Taenia spp., and Enterobius vermicularis. Hookworms, Trichuris trichiura, Schistosoma mansoni, Heterophyidae/Opisthorchidae and Trichostrongylus spp. were occasionally missed.Discussion  AMPLIQUICK® demonstrated good performance compared to the conventional methods and has the potential to improve parasitology diagnostics, particularly in laboratories with limited expertise. Clinicians should interpret findings in the patient's clinical context.
SN  - 2235-2988
ER  -